Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $18.59 USD
Change Today -0.24 / -1.27%
Volume 345.8K
AEGR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc D. Beer

Chief Executive Officer and Director, Aegerion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 5 different organizations across 8 different industries.

See Board Relationships
50$4,198,531
As of Fiscal Year 2014

Background*

Mr. Marc D. Beer has been the Chief Executive Officer at Aegerion Pharmaceuticals, Inc. since August 19, 2010. Mr. Beer founded ViaCell, Inc., and served as its President and Chief Executive Officer from April 2000 to November 2007. Prior to that, from April 1996 to 2000, he held marketing and business development roles at Genzyme Corporation, Sanofi pharmaceutical company, served as Vice President of Global Marketing. From 1996 to April 2000, he served as Senior Manager ...

Read Full Background

Corporate Headquarters*

One Main Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-7867
Fax: 617-945-7968

Board Members Memberships*

Director
Chairman of The Board
2000-N/A
Former Chief Executive Officer, President and Director
2010-Present
Chief Executive Officer and Director
2010-Present
Director
2011-2014
Former Director
2013-Present
Chairman, Chairman of Compensation Committee and Member of Audit Committee

Education*

BSBA
Miami University

Other Affiliations*

Annual Compensation*

Salary$635,000
Total Annual Compensation$635,000

Stock Options*

All Other Compensation$46,811
Exercised Options9,400
Exercisable Options1,057,456
Exercisable Options Value$15,367,756
Unexercisable Options175,417
Unexercisable Options Value$137,680
Total Value of Options$15,505,436
Total Number of Options1,449,773

Total Compensation*

Total Annual Cash Compensation$681,811
Total Short Term Compensation$635,000
Other Long Term Compensation$46,811
Total Calculated Compensation$4,198,531
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEGR:US $18.59 USD -0.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.